eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Abbott Laboratories Limited
Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 22/12/2011
PIL Humira 40mg solution for injection in pre-filled pen

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/06/2011 and displayed until 22/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 03/03/2011 and displayed until 15/06/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/10/2010 and displayed until 03/03/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about driving or using machinery
Updated on 05/07/2010 and displayed until 19/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 21/05/2010 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 10/08/2009 and displayed until 21/05/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/05/2009 and displayed until 10/08/2009
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 16/03/2009 and displayed until 01/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 14/10/2008 and displayed until 16/03/2009
Reasons for adding or updating:
  • Change to information about driving or using machinery
  • Change to dosage and administration
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 04/07/2008 and displayed until 14/10/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  adalimumab